title: Ticagrelor-induced acute generalized exanthematous pustulosis.
authors.affiliation: University of Kansas Medical Center, Division of Cardiology, Kansas City, KS, United States. Electronic address: rmaybrook@kumc.edu.
authors.forename: Ryan J
authors.initials: RJ
authors.lastname: Maybrook
authors.affiliation: University of Kansas Medical Center, Division of Dermatology, Kansas City, KS, United States.
authors.forename: Ryan
authors.initials: R
authors.lastname: Fischer
authors.affiliation: University of Kansas School of Medicine, Kansas City, KS, United States.
authors.forename: Brent
authors.initials: B
authors.lastname: Deibert
authors.affiliation: University of Kansas School of Medicine, Kansas City, KS, United States.
authors.forename: Ryan
authors.initials: R
authors.lastname: Gillihan
authors.affiliation: University of Kansas Medical Center, Division of Dermatology, Kansas City, KS, United States.
authors.forename: Rachel
authors.initials: R
authors.lastname: Laarman
authors.affiliation: University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS, United States.
authors.forename: Garth
authors.initials: G
authors.lastname: Fraga
authors.affiliation: University of Kansas Medical Center, Division of Dermatology, Kansas City, KS, United States.
authors.forename: Daniel
authors.initials: D
authors.lastname: Aires
authors.affiliation: University of Kansas Medical Center, Division of Cardiology, Kansas City, KS, United States.
authors.forename: Steven
authors.initials: S
authors.lastname: Gollub
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy; D056150:Acute Generalized Exanthematous Pustulosis / Q000209:etiology* / Q000473:pathology; D000241:Adenosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000368:Aged; D001706:Biopsy; D000077144:Clopidogrel; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077144:Clopidogrel; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine
keywords: Acute generalized exanthematous pustulosis; Clopidogrel; Dual antiplatelet therapy; P2Y12 antagonist; Ticagrelor